Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus.

Our data support a diverse molecular profile in CLE that further adds to the clinical variations of this skin disease, and may affect disease course and treatment selection. Future studies with a larger and diverse cohort of patients with CLE are warranted to confirm these findings.